← Eichor
Study identifier: NCT04534127 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

Condition: Skin Cancer · Mucosal Neoplasm of Oral Cavity · Soft Tissue Neoplasm  ·  Sponsor: Alpha Tau Medical LTD.

PhaseNA
Planned participants56
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for superficial cutaneous, mucosal or soft tissue neoplasia

This description comes directly from the study's public registry record.

Talk to the study team

Liron Dimnik  ·  +972-2-373-7000  ·  LironD@alphatau.com

Always discuss trial participation with your own doctor first.

Locations (1)

Sharett institute, Hadassah Medical Center - Ein-KeremJerusalem, IsraelRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04534127